| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |